Abstract
No AccessJournal of UrologyOncology: Prostate/Testis/Penis/Urethra1 Jan 2013Editorial Comment Robert Coleman Robert ColemanRobert Coleman More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.11.057AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 189(1S), pp. S57–S58 References 1 : Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol2005; 23: 4925. Google Scholar Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom© 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 1SJanuary 2013Page: S57-S58 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Robert Coleman More articles by this author Expand All Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
